Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01071239 · ClinicalTrials.gov registry record · Phase 2

Hematopoietic Stem Cell Transplant for Fanconi Anemia

A Phase 2 study of Fanconi Anemia, sponsored by Medical College of Wisconsin.

Completed
Registry status
Phase 2
Development phase
1
Enrollment target
1
Study location

NCT01071239 is a Phase 2 study of Fanconi Anemia that has completed, run by Medical College of Wisconsin. The registered enrollment target is 1 participants, below the 336-participant average among 15 other Fanconi Anemia trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01071239, a Phase 2 study of Fanconi Anemia, has completed, sponsored by Medical College of Wisconsin.

COMPLETED
Registry status
Phase 2
Development phase
1 participants
Enrollment target
1
Study location

Study Summary

The trial proposed is a single arm phase II treatment protocol designed to examine engraftment, toxicity, graft-versus-host disease, and ultimate disease-free survival following a novel cytoreductive regimen including busulfan, cyclophosphamide and fludarabine and anti-thymocyte globulin (ATG- a non-chemotherapy drug whose role is to kill your immune system) for the treatment of patients with Fanconi anemia who have severe aplastic anemia (SAA), or myelodysplastic syndrome (MDS) or acute myelogenous leukemia (AML), lacking HLA-genotypically identical donors using stem cell transplants derived from (1) HLA-compatible unrelated donors or (2) HLA haplotype-mismatched related donors.

Conditions Studied

Fanconi Anemia

Interventions

  • DRUG Cyclophosphamide
  • DRUG Fludarabine
  • DRUG Busulfan
  • DRUG ATG
  • DEVICE CliniMACs device

Study Locations (1)

Wisconsin

  • Medical College of Wisconsin - Milwaukee

Trial Details

FieldValue
Enrollment Target 1 participants
Start Date 2009-04
Est. Completion 2016-08-30
Phase Phase 2

Sponsor

Medical College of Wisconsin

447 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01071239

The ClinicalTrials.gov registry entry for NCT01071239 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 336-participant average among 15 other Fanconi Anemia trials with a reported enrollment target (100% lower). The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Fanconi Anemia appearing as the primary indexed condition, and to 5 interventions - of which Cyclophosphamide is the first listed.

NCT01071239 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.

Frequently Asked Questions

What is clinical trial NCT01071239 about?

NCT01071239 is a clinical study titled "Hematopoietic Stem Cell Transplant for Fanconi Anemia". The trial proposed is a single arm phase II treatment protocol designed to examine engraftment, toxicity, graft-versus-host disease, and ultimate disease-free survival following a novel cytoreductive regimen including busulfan, cyclophosphamide and fludarabine and anti-thymocyte globulin (ATG- a non...

What is the current status of trial NCT01071239?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 1 participants. The study started on 2009-04. Estimated completion is 2016-08-30.

What conditions does trial NCT01071239 study?

This clinical trial studies the following conditions: Fanconi Anemia.

What interventions are being tested in trial NCT01071239?

The interventions under investigation include: Cyclophosphamide (DRUG), Fludarabine (DRUG), Busulfan (DRUG), ATG (DRUG), CliniMACs device (DEVICE).

Who is sponsoring clinical trial NCT01071239?

This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01071239 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Fanconi Anemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Fanconi Anemia

All registered trials for this condition

Wisconsin

All trials with a study site in Wisconsin

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.